Anne Wojcicki’s TTAM Research Institute has received court approval to acquire 23andMe, the genetic testing company she co-founded. The $305 million US dollar deal follows 23andMe’s Chapter 11 bankruptcy filing in March, and a bidding war with Regeneron Pharmaceuticals. Katherine Ward has this story and more in Health Matters for Wednesday July 2, 2025.
Health Matters
Health Matters: Wojcicki’s nonprofit approved to buy 23andMe
More Videos
-
Health Matters: WHO pushing for 50 per cent tax hike on tobacco, alcohol, and sugary drinks
-
Health Matters: Concern over measles spreading within Canada this summer
-
Health Matters: U.S. pulls funding from global vaccines group
-
Health Matters: Ontario, Quebec still under heat dome
-
Health Matters: 23AndMe, measles case counts and summer respiratory health
You are viewing an .
View Original Article